{
    "mtblsStudy": {
        "studyStatus": "Public",
        "curationRequest": "MANUAL_CURATION",
        "modifiedTime": "2020-11-19T00:00:00",
        "statusUpdateTime": "2020-11-19T16:02:56.071699",
        "read_access": true,
        "write_access": false,
        "is_curator": false
    },
    "isaInvestigation": {
        "comments": [
            {
                "name": "Created With Configuration",
                "value": ""
            },
            {
                "name": "Last Opened With Configuration",
                "value": ""
            }
        ],
        "identifier": "MTBLS563",
        "title": "Investigation",
        "description": "",
        "submissionDate": "2017-10-27",
        "publicReleaseDate": "2020-11-19",
        "filename": "",
        "people": [],
        "publications": [],
        "ontologySourceReferences": [
            {
                "comments": [],
                "name": "NCBITAXON",
                "file": "http://data.bioontology.org/ontologies/NCBITAXON",
                "version": "2",
                "description": "National Center for Biotechnology Information (NCBI) Organismal Classification"
            },
            {
                "comments": [],
                "name": "DOID",
                "file": "http://data.bioontology.org/ontologies/DOID",
                "version": "568",
                "description": "Human Disease Ontology"
            },
            {
                "comments": [],
                "name": "CHEBI",
                "file": "http://data.bioontology.org/ontologies/CHEBI",
                "version": "80",
                "description": "Chemical Entities of Biological Interest Ontology"
            },
            {
                "comments": [],
                "name": "BTO",
                "file": "http://data.bioontology.org/ontologies/BTO",
                "version": "33",
                "description": "BRENDA Tissue and Enzyme Source Ontology"
            },
            {
                "comments": [],
                "name": "CHMO",
                "file": "http://data.bioontology.org/ontologies/CHMO",
                "version": "18",
                "description": "Chemical Methods Ontology"
            },
            {
                "comments": [],
                "name": "MESH",
                "file": "http://data.bioontology.org/ontologies/MESH",
                "version": "10",
                "description": "Medical Subject Headings"
            },
            {
                "comments": [],
                "name": "IDO",
                "file": "http://data.bioontology.org/ontologies/IDO",
                "version": "8",
                "description": "Infectious Disease Ontology"
            },
            {
                "comments": [],
                "name": "OAE",
                "file": "http://data.bioontology.org/ontologies/OAE",
                "version": "124",
                "description": "Ontology of Adverse Events"
            },
            {
                "comments": [],
                "name": "NCIT",
                "file": "http://data.bioontology.org/ontologies/NCIT",
                "version": "44",
                "description": "National Cancer Institute Thesaurus"
            },
            {
                "comments": [],
                "name": "OBI",
                "file": "http://data.bioontology.org/ontologies/OBI",
                "version": "22",
                "description": "Ontology for Biomedical Investigations"
            },
            {
                "comments": [],
                "name": "UO",
                "file": "http://data.bioontology.org/ontologies/UO",
                "version": "43",
                "description": "Units of Measurement Ontology"
            },
            {
                "comments": [],
                "name": "EFO",
                "file": "",
                "version": "",
                "description": ""
            }
        ],
        "studies": [
            {
                "comments": [
                    {
                        "name": "Study Funding Agency",
                        "value": ""
                    },
                    {
                        "name": "Study Grant Number",
                        "value": ""
                    }
                ],
                "identifier": "MTBLS563",
                "filename": "s_MTBLS563.txt",
                "title": "NMR-based metabolic profiling provides diagnostic and prognostic information in critically ill children with suspected infection",
                "description": "<p>Sepsis, defined as life-threatening organ dysfunction caused by infection is difficult to distinguish clinically from infection or post-operative inflammation. We hypothesized that in a heterogeneous group of critically ill children, there would be different metabolic profiles between post-operative inflammation, bacterial and viral infection and infection with or without organ dysfunction. 1D 1H nuclear magnetic resonance spectra were acquired in plasma samples from critically ill children. We included children with bacterial (n\u2009=\u200925) and viral infection (n\u2009=\u200930) and controls (n\u2009=\u200958) (elective cardiac surgery without infection). Principal component analysis was used for data exploration and partial least squares discriminant analysis models for the differences between groups. Area under receiver operating characteristic curve (AUC) values were used to evaluate the models. Univariate analysis demonstrated differences between controls and bacterial and viral infection. There was excellent discrimination between bacterial and control (AUC\u2009=\u20090.94), and viral and control (AUC\u2009=\u20090.83), with slightly more modest discrimination between bacterial and viral (AUC\u2009=\u20090.78). There was modest discrimination (AUC\u2009=\u20090.73) between sepsis with organ dysfunction and infection with no organ dysfunction. In critically ill children, NMR metabolomics differentiates well between those with a post-operative inflammation but no infection, and those with infection (bacterial and viral), and between sepsis and infection.</p>",
                "submissionDate": "2017-10-27",
                "publicReleaseDate": "2020-11-19",
                "people": [
                    {
                        "comments": [],
                        "firstName": "Arturas",
                        "lastName": "Grauslys",
                        "email": "agraus@liverpool.ac.uk",
                        "affiliation": "Institute of Integrative Biology",
                        "address": "Biosciences Building, Crown Street, L69 7ZB, UK",
                        "fax": "",
                        "midInitials": "",
                        "phone": "",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Responsible Scientist",
                                "termSource": null,
                                "termAccession": ""
                            }
                        ]
                    },
                    {
                        "comments": [],
                        "firstName": "Marie",
                        "lastName": "Phelan",
                        "email": "mphelan@liverpool.ac.uk",
                        "affiliation": "Technology Directorate, University of Liverpool",
                        "address": "NMR Centre for Structural Biology, Crown Street, L69 7ZB, UK",
                        "fax": "",
                        "midInitials": "M",
                        "phone": "+44 151 795 4398",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Responsible Scientist",
                                "termSource": null,
                                "termAccession": ""
                            }
                        ]
                    },
                    {
                        "comments": [],
                        "firstName": "Enitan",
                        "lastName": "Carrol",
                        "email": "edcarrol@liverpool.ac.uk",
                        "affiliation": "Institute of Infection and Global Health",
                        "address": "Ronald Ross Building, 8 West Derby Street, L69 7BE, UK",
                        "fax": "",
                        "midInitials": "D",
                        "phone": "+44 151 794 9535",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "Principal Investigator",
                                "termSource": null,
                                "termAccession": ""
                            }
                        ]
                    }
                ],
                "studyDesignDescriptors": [
                    {
                        "comments": [],
                        "annotationValue": "bacterial sepsis AE",
                        "termSource": {
                            "comments": [],
                            "name": "OAE",
                            "file": "http://data.bioontology.org/ontologies/OAE",
                            "version": "124",
                            "description": "Ontology of Adverse Events"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/OAE_0000700"
                    },
                    {
                        "comments": [],
                        "annotationValue": "viral infection AE",
                        "termSource": {
                            "comments": [],
                            "name": "OAE",
                            "file": "http://data.bioontology.org/ontologies/OAE",
                            "version": "124",
                            "description": "Ontology of Adverse Events"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/OAE_0000466"
                    },
                    {
                        "comments": [],
                        "annotationValue": "sepsis AE",
                        "termSource": {
                            "comments": [],
                            "name": "OAE",
                            "file": "http://data.bioontology.org/ontologies/OAE",
                            "version": "124",
                            "description": "Ontology of Adverse Events"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/OAE_0000618"
                    },
                    {
                        "comments": [],
                        "annotationValue": "Intensive Care Units, Pediatric",
                        "termSource": {
                            "comments": [],
                            "name": "MESH",
                            "file": "http://data.bioontology.org/ontologies/MESH",
                            "version": "10",
                            "description": "Medical Subject Headings"
                        },
                        "termAccession": "http://purl.bioontology.org/ontology/MESH/D015278"
                    },
                    {
                        "comments": [],
                        "annotationValue": "viral infectious disease",
                        "termSource": {
                            "comments": [],
                            "name": "DOID",
                            "file": "http://data.bioontology.org/ontologies/DOID",
                            "version": "568",
                            "description": "Human Disease Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/DOID_934"
                    },
                    {
                        "comments": [],
                        "annotationValue": "systemic infection",
                        "termSource": {
                            "comments": [],
                            "name": "IDO",
                            "file": "http://data.bioontology.org/ontologies/IDO",
                            "version": "8",
                            "description": "Infectious Disease Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/IDO_0000474"
                    },
                    {
                        "comments": [],
                        "annotationValue": "local infection",
                        "termSource": {
                            "comments": [],
                            "name": "IDO",
                            "file": "http://data.bioontology.org/ontologies/IDO",
                            "version": "8",
                            "description": "Infectious Disease Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/IDO_0000475"
                    },
                    {
                        "comments": [],
                        "annotationValue": "focal infection",
                        "termSource": {
                            "comments": [],
                            "name": "IDO",
                            "file": "http://data.bioontology.org/ontologies/IDO",
                            "version": "8",
                            "description": "Infectious Disease Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/IDO_0000476"
                    },
                    {
                        "comments": [],
                        "annotationValue": "acute infection",
                        "termSource": {
                            "comments": [],
                            "name": "IDO",
                            "file": "http://data.bioontology.org/ontologies/IDO",
                            "version": "8",
                            "description": "Infectious Disease Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/IDO_0000627"
                    },
                    {
                        "comments": [],
                        "annotationValue": "hospital-acquired/nosocomial infection",
                        "termSource": null,
                        "termAccession": ""
                    },
                    {
                        "comments": [],
                        "annotationValue": "community-acquired infection",
                        "termSource": {
                            "comments": [],
                            "name": "IDO",
                            "file": "http://data.bioontology.org/ontologies/IDO",
                            "version": "8",
                            "description": "Infectious Disease Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/IDO_0000631"
                    },
                    {
                        "comments": [],
                        "annotationValue": "Clinical Diagnosis",
                        "termSource": {
                            "comments": [],
                            "name": "NCIT",
                            "file": "http://data.bioontology.org/ontologies/NCIT",
                            "version": "44",
                            "description": "National Cancer Institute Thesaurus"
                        },
                        "termAccession": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15607"
                    },
                    {
                        "comments": [],
                        "annotationValue": "untargeted metabolites",
                        "termSource": null,
                        "termAccession": ""
                    },
                    {
                        "comments": [],
                        "annotationValue": "nuclear magnetic resonance spectroscopy",
                        "termSource": {
                            "comments": [],
                            "name": "CHMO",
                            "file": "http://data.bioontology.org/ontologies/CHMO",
                            "version": "18",
                            "description": "Chemical Methods Ontology"
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHMO_0000591"
                    }
                ],
                "publications": [
                    {
                        "comments": [],
                        "title": "NMR-based metabolic profiling provides diagnostic and prognostic information in critically ill children with suspected infection.",
                        "authorList": "Arturas Grauslys,   Marie M Phelan, Caroline Broughton, Paul B Baines,  Rebecca Jennings, Sarah Siner, Stephane C Paulus, Enitan D Carrol",
                        "pubMedID": "",
                        "doi": "10.1038/s41598-020-77319-0",
                        "status": {
                            "comments": [],
                            "annotationValue": "Published",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "",
                                "version": "",
                                "description": ""
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0001796"
                        }
                    }
                ],
                "factors": [
                    {
                        "comments": [],
                        "factorName": "Diagnosis",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "Diagnosis",
                            "termSource": {
                                "comments": [],
                                "name": "NCIT",
                                "file": "http://data.bioontology.org/ontologies/NCIT",
                                "version": "44",
                                "description": "National Cancer Institute Thesaurus"
                            },
                            "termAccession": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15220"
                        }
                    }
                ],
                "protocols": [
                    {
                        "comments": [],
                        "name": "Sample collection",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Sample collection",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Sample groups for the purpose of determining a clean phenotype were defined as infants and children older than 4 weeks with an age range of 4 weeks\u201314.33 years of age (0.08\u201314.33). All eligible patients as defined by the sample group criteria were selected for the bacterial and viral infection groups. To reduce effect of age and gender the control group samples were selected to match as closely as possible with gender split in the sample groups between 36 and 50% (see <strong>Table 1</strong> in the paper associated with this study).</p><p><br></p><p>Patients were assigned to diagnostic groups using previously published predefined criteria<strong>[1]</strong>. The following definitions were used:</p><p><br></p><p><strong>Definite bacterial infection:</strong> children with culture or PCR-confirmed infection from a sterile site.</p><p><strong>Definite viral infection:</strong> children with PCR or immunofluorescent test\u2013confirmed viral infection and no features of co-existing bacterial infection.</p><p><strong>Sepsis:</strong> life-threatening organ dysfunction caused by a dysregulated host response to infection<strong>[2]</strong>. Organ dysfunction was previously defined<strong>[3]</strong> and Multiple Organ Dysfunction (MOD) defined as or two or more organ dysfunctions (respiratory, renal, neurologic, hematologic, or hepatic).</p><p><strong>Controls:</strong> post-operative cardiac surgery patients admitted electively to critical care, in whom no infection was diagnosed. These patients have previously been described, and had evidence of post-operative inflammation with raised Procalcitonin and C-reactive protein on post-operative day 2 and 3<strong>[4]</strong>.</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Herberg JA, Kaforou M, Wright VJ, Shailes H, Eleftherohorinou H, Hoggart CJet al.; IRIS Consortium. Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children. JAMA. 2016 Aug 23-30;316(8):835-45. doi:10.1001/jama.2016.11236. Erratum in: JAMA. 2017 Feb 7;317(5):538. PMID:27552617.</p><p><strong>[2]</strong> Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo Ret al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi:10.1001/jama.2016.0287. PMID:26903338.</p><p><strong>[3]</strong> Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005 Jan;6(1):2-8. doi:10.1097/01.PCC.0000149131.72248.E6. PMID:15636651.</p><p><strong>[4]</strong> D'Souza S, Guhadasan R, Jennings R, Siner S, Paulus S, Thorburn K, Chesters C, Downey C, Baines P, Lane S, Carrol E. Procalcitonin and Other Common Biomarkers Do Not Reliably Identify Patients at Risk for Bacterial Infection After Congenital Heart Surgery. Pediatr Crit Care Med. 2019 Mar;20(3):243-251. doi:10.1097/PCC.0000000000001826. PMID:30575697.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Extraction",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Extraction",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "No extraction was performed in this study.",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Extraction Method",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "NMR sample",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "NMR sample",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>100 \u00b5l of serum was thawed on ice before addition of buffer to create a final sample composition of 100 mM sodium phosphate pH 7.40, 0.02% (w/v) sodium azide to a final volume of 200 \u03bcl containing 10% 2H2O. The sample was vortexed for 30 s and then centrifuged (21,500 x g, 4 \u00b0C, 5 min). 180 \u03bcl of supernatant was then transferred to a 3 mm outer diameter NMR tube using a glass Pasteur with care taken not to disturb any pelleted material.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "NMR tube type",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Temperature",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Sample pH",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Solvent",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "NMR spectroscopy",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "NMR spectroscopy",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>1D 1H NMR spectra were acquired on a Bruker Avance III HD 700 spectrometer equipped with a 5 mm TCI cryoprobe and SampleJet autosampler at pH 7.4 and 37 \u00b0C.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Magnetic field strength",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Number of transients",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Pulse sequence name",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "NMR Probe",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "NMR assay",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "NMR assay",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>1D 1H NMR standard vendors pulse sequence with the cpmgpr1d using Carr-Purcell-Meiboom-Gill (CPMG) filters for selective observation of low molecular weight components with optimal water suppression was used. Spectra were acquired with 32 transients a 20 ppm spectral width, 64 K points, 9.6 ms echo time and a 3.1 s acquisition time and a 4 s interscan delay.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Data transformation",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Data transformation",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Automated data processing, Fourier transformation, and phasing were performed in Topspin v3.2 (Topspin 3.2.pl7 <a href='https://www.bruker.com/products/mr/nmr/software/topspin.html' rel='noopener noreferrer' target='_blank'>https://www.bruker.com/products/mr/nmr/software/topspin.html</a>) software using standard Bruker routines. The spectra were referenced indirectly to TSP via the anomeric glucose doublet at 5.204 ppm and then normalised to via probabilistic quotient normalisation<strong>[1]</strong>. The spectra were then bucketed per peak into a matrix of metabolite peak intensities using custom R scripts.</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Kohl SM, Klein MS, Hochrein J, Oefner PJ, Spang R, Gronwald W. State-of-the art data normalization methods improve NMR-based metabolomic analysis. Metabolomics. 2012 Jun;8(Suppl 1):146-160. doi:10.1007/s11306-011-0350-z. PMID:22593726.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Metabolite identification",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Metabolite identification",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "<p>Chenomx v 8.2 (Chenomx 8.2 <a href='https://www.chenomx.com/' rel='noopener noreferrer' target='_blank'>https://www.chenomx.com/</a>) software was used for initial metabolite annotation followed by manual confirmation of identities using in-house standards for metabolite peaks. Identification and annotation levels are reported in the deposited data according to Metabolomics standards initiative guidelines<strong>[1]-[4]</strong>.</p><p><br></p><p>Multivariate statistical analysis was performed using R statistical computing environment. Principal component analysis (PCA) was then used for exploration of data and outlier identification. Four samples were removed as outliers after inspection of PCA scores plots. The samples were split into 4 groups (control, bacterial infection, viral infection, unclear) according to standard diagnostic guidelines. The relative metabolite concentrations were compared between groups using a one-way ANOVA with Tukey\u2019s post-hoc analysis.</p><p><br></p><p><strong>Ref:</strong></p><p><strong>[1]</strong> Salek RM, Haug K, Conesa P, Hastings J, Williams M, Mahendraker T, Maguire E, Gonz\u00e1lez-Beltr\u00e1n AN, Rocca-Serra P, Sansone SA, Steinbeck C. The MetaboLights repository: curation challenges in metabolomics. Database (Oxford). 2013 Apr 29;2013:bat029. doi:10.1093/database/bat029. PMID:23630246.</p><p><strong>[2]</strong> Salek RM, Haug K, Steinbeck C. Dissemination of metabolomics results: role of MetaboLights and COSMOS. Gigascience. 2013 May 17;2(1):8. doi:10.1186/2047-217X-2-8. PMID:23683662.</p><p><strong>[3]</strong> Salek RM, Steinbeck C, Viant MR, Goodacre R, Dunn WB. The role of reporting standards for metabolite annotation and identification in metabolomic studies. Gigascience. 2013 Oct 16;2(1):13. doi:10.1186/2047-217X-2-13. PMID:24131531.</p><p><strong>[4]</strong> Verreault J, Lepage S, Bisson G, Plante A. Ascites and right pleural effusion: demonstration of a peritoneo-pleural communication. J Nucl Med. 1986 Nov;27(11):1706-9. PMID:3772505.</p>",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    }
                ],
                "assays": [
                    {
                        "comments": [],
                        "measurementType": {
                            "comments": [],
                            "annotationValue": "metabolite profiling",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "22",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000366"
                        },
                        "technologyType": {
                            "comments": [],
                            "annotationValue": "NMR spectroscopy",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "22",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000623"
                        },
                        "technologyPlatform": "Bruker",
                        "filename": "a_MTBLS563_metabolite_profiling_NMR_spectroscopy.txt",
                        "dataFiles": [],
                        "processSequence": [],
                        "sources": [],
                        "samples": [],
                        "otherMaterials": [],
                        "characteristicCategories": [],
                        "units": [],
                        "graph": null
                    }
                ],
                "sources": [],
                "samples": [],
                "processSequence": [],
                "characteristicCategories": [],
                "units": []
            }
        ]
    },
    "validation": {
        "errors": [],
        "warnings": []
    }
}